Biotage, Investor relations

Interim report January - June 2010

Biotage AB (publ) - disclosure notice of substantial holding of shares

Biotage appoints Anders Wikström as Vice President of Operations and Anthony Rees as Chief Scientific Officer

Biotage Introduces Resolux™ Peptides Purification HPLC Columns

New Isolera™ UV-VIS Flash Purification System delivers widest wavelength range available to chemists (Copy)

Biotage Launches New Isolera™ ELS Detector, Helps Isolate Virtually Any Compound

Biotage Introduces Highly-Selective ExploraSep 96-Well Screening Plates based on Molecularly Imprinted Polymers

European Peptide SymposiumBiotage are Gold Sponsors.
5th - 9th September
Copenhagen, DenmarkILMAC 201021st - 24th September
Basel, SwitzerlandAOACAugust 27-28
Orlando, FL27th Montreux Symposium on LC/MS 10th - 12th November
Montreux, SwitzerlandThe 3rd EBF Open Symposium 1st - 3rd December
Barcelona, Spain

Information for shareholders, analysts and potential investors	Corporate Governace Press Releases Financial Reports Latest Annual Report Calendar Contacts Subscribe
Biotage is listed on the NASDAQ OMX Nordic Stockholm Stock Exchange. The stock exchange identity is BIOT.

Print page